Last $0.09 USD
Change Today +0.0028 / 3.29%
Volume 66.3K
RBCC On Other Exchanges
Symbol
Exchange
OTC BB
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

rainbow coral corp (RBCC) Snapshot

Open
$0.08
Previous Close
$0.09
Day High
$0.09
Day Low
$0.08
52 Week High
01/23/14 - $0.30
52 Week Low
05/16/14 - $0.05
Market Cap
1.8M
Average Volume 10 Days
42.1K
EPS TTM
--
Shares Outstanding
20.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for RAINBOW CORAL CORP (RBCC)

Related News

No related news articles were found.

rainbow coral corp (RBCC) Related Businessweek News

No Related Businessweek News Found

rainbow coral corp (RBCC) Details

Rainbow Coral Corp., through its subsidiary, Rainbow Biosciences, LLC, focuses on identifying, developing, and marketing bioscience solutions for physicians, researchers, and pharmaceutical engineers. The company, through its joint venture with Nano3D Biosciences, is involved in developing and marketing the BiO Assay, the commercially available 3D bioprinter designed specifically for rapid, high-volume drug screening. Its automated toxicity assay uses biocompatible magnetic nanoparticles to print cells into 3D structures. The company also has partnership with Therakine to market and develop a new injectable, sustained-release technology poised to enhance patients’ use of a crucial drug in the fight against drug and alcohol dependence. Rainbow Coral Corp. was incorporated in 2010 and is based in Miramar Beach, Florida.

2 Employees
Last Reported Date: 07/16/13
Founded in 2010

rainbow coral corp (RBCC) Top Compensated Officers

Principal Financial Officer, Principal Accoun...
Total Annual Compensation: $66.0K
Compensation as of Fiscal Year 2013.

rainbow coral corp (RBCC) Key Developments

Rainbow Coral Corp. announced delayed annual 10-K filing

On 07/01/2014, Rainbow Coral Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Rainbow Coral Corp. announced delayed 10-Q filing

On 02/18/2014, Rainbow Coral Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Rainbow Coral Corp. Moves to the Front Lines of the 3D Bioprinting Revolution

Rainbow Coral Corp. is well positioned to capitalize on the revolution in medicine being spurred on by 3D printing technology, a new 3D bioprinting system developed by RBCC's joint venture partner, Nano3D Biosciences. The BiO Assay uses magnetism to assemble cells in 3D and into conditions that closely mimic those found in vivo, giving drug makers functional preclinical human tissues far more useful than any animal or test tube models. And with better testing results will come bigger profits for drug companies. The BiO Assay represents a revolution in pharmaceutical research, offering better and faster results than have previously been possible. RBCC formed a biotech subsidiary, Rainbow Biosciences, to market and develop new medical and research technology innovations to compete alongside companies such as Biogen Idec Inc., Abbott Laboratories and Amgen Inc.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RBCC:US $0.09 USD +0.0028

RBCC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RBCC.
View Industry Companies
 

Industry Analysis

RBCC

Industry Average

Valuation RBCC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 14.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 13.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RAINBOW CORAL CORP, please visit www.rainbowbiosciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.